144
Views
67
CrossRef citations to date
0
Altmetric
Original Research

Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle

, , , &
Pages 5137-5149 | Published online: 27 Sep 2012

References

  • PankhurstQAConnollyJJonesSKDobsonJApplications of magnetic nanoparticles in biomedicineJ Phys D Appl Phys200336R167R181
  • GuptaAKGuptaMSynthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials2005263995402115626447
  • SunCLeeJSHZhangMQMagnetic nanoparticles in MR imaging and drug deliveryAdv Drug Deliv Rev2008601252126518558452
  • FiguerolaaADi CoratobRMannaaLPellegrinoaTFrom iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applicationsPharmacol Res20106212614320044004
  • GanSYChowMCarboxyl group (-CO2H) functionalized ferromagnetic iron oxide nanoparticles for potential bio-applicationsJ Mater Chem20041427812786
  • SunSMaMQiuNAffinity adsorption and separation behaviors of avidin on biofunctional magnetic nanoparticles binding to iminobiotinColloid Surface B201188246253
  • KaushikAKhanRSolankiPRIron oxide nanoparticles-chitosan composite based glucose biosensorBiosens Bioelectron20082467668318692384
  • SunJZhouSBHouPSynthesis and characterization of biocompatible Fe3O4 nanoparticlesJ Biomed Mater Res200680A333341
  • ButterworthMDIllumLDavisSSPreparation of ultrafine silica-and PEG-coated magnetite particlesColloid Surface B200117993102
  • FangCZhangMMultifunctional magnetic nanoparticles for medical imaging applicationsJ Mater Chem2009196258626620593005
  • KohlerNFryxellGEZhangMA bifunctional poly(ethylene glycol) silane immobilized on metallic oxide-based nanoparticles for conjugation with cell targeting agentsJ Am Chem Soc20041267206701115186157
  • BarbeCBartlettJKongLFinnieKLinHQLarkinMSilica particles: a novel drug-delivery systemAdv Mater20041619591966
  • JainTKRoyIDeTKMaitraANNanometer silica particles encapsulating active compounds: A novel ceramic drug carrierJ Am Chem Soc19981201109211095
  • ChenFHGaoQNiJZThe grafting and release behavior of doxorubincin from Fe3O4@SiO2 core-shell structure nanoparticles via an acid cleaving amide bond: the potential for magnetic targeting drug deliveryNanotechnology20081916510321825634
  • ArrueboMGalánMNavascuésNDevelopment of magnetic nanostructured silica-based materials as potential vectors for drug-delivery applicationsChem Mater20061819111919
  • ZhouLWuWCaruntuDSynthesis of porous magnetic hollow silica nanospheres for nanomedicine applicationJ Phys Chem C20071111747317477
  • SantraSTapecRTheodoropoulouNDobsonJHebardATanWHSynthesis and characterization of silica-coated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactantsLangmuir20011729002906
  • YiDKSelvanSTLeeSSPapaefthymiouGCKundaliyaDYingJYSilica-coated nanocomposites of magnetic nanoparticles and quantum dotsJ Am Chem Soc20051274990499115810812
  • LiCMaCWangFPreparation and biomedical applications of core-shell silica/magnetic nanoparticle compositesJ Nanosci Nanotechnol2012122964297222849053
  • YangCQWangGLuZYSunJZhuangJQYangWSEffect of ultrasonic treatment on dispersibility of Fe3O4 nanoparticles and synthesis of multi-core Fe3O4/SiO2 core/shell nanoparticlesJ Mater Chem20051542524257
  • LuZYWangGZhuangJQYangWSEffects of the concentration of tetramethylammonium hydroxide peptizer on the synthesis of Fe3O4/SiO2 core/shell nanoparticlesColloid Surface A2006278140143
  • SegalJBEngJTamarizLJBassEBReview of the evidence on diagnosis of deep venous thrombosis and pulmonary embolismAnn Fam Med20075637317261866
  • LøvlienMJohanssonIHoleTScheiBEarly warning signs of an acute myocardial infarction and their influence on symptoms during the acute phase with comparisons by genderGend Med2009644445319850240
  • AndersonHVWillersonJTThrombolysis in acute myocardial infarctionNew Engl J Med19933297037098345856
  • van der WorpHBvan GijnJClinical practice: acute ischemic strokeNew Eng J Med200735757257917687132
  • BennettWPaoniNKeytBHigh resolution analysis of functional determination of human tissue-type plasminogen activatorJ Biol Chem1991266519155201900516
  • BergerHPizzoSPreparation of polyethylene glycol-tissue plasminogen activator adducts that retain functional activity: characteristics and behavior in three animal speciesBlood198871164116473370312
  • StrickerRBWongDShiuDTReyesPTShumanMAActivation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregationBlood1986682752802941084
  • XieYKaminskiMDTornoMDFinckMRLiuXRosengartAJPhysicochemical characteristics of magnetic microspheres containing tissue plasminogen activatorJ Magn Magn Mater2007311376378
  • KaminskiMDXieYMertzCJFinckMRChenHRosengartAJEncapsulation and release of plasminogen activator from biodegradable magnetic microcarriersEur J Pharm Sci2008359610318644439
  • MaYHWuSYWuTChangYJHuaMYChenJPMagnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acidBiomaterials200930343351
  • WuTHuaMYChenJPWeiKCJungSMChangYJEffects of external magnetic field on biodistribution of nanoparticles: a histological studyJ Magn Magn Mater2007311372375
  • JanolinoVJSwaisgoodHEA spectrophotometric assay for solid phase primary amino groupsAppl Biochem Biotechnol1992368185
  • LiangJFSongHLiYTYangVCA novel heparin/protamine-based pro-drug type delivery system for protease drugsJ Pharma Sci200089664673
  • BernyMAPatelIAWhite-AdamsTCRational design of an ex vivo model of thrombosisCell Mol Bioeng20103187189
  • StöberWFinkABohnEControlled growth of monodisperse silica spheres in the micron size rangeJ Colloid Interf Sci1968266269
  • PhilipseAPVan BruggenMPBPathmamanoharanCMagnetic silica dispersions: preparation and stability of surface-modified silica particles with a magnetic coreLangmuir1994109299
  • PanellaBVargasAFerriDBaikerAChemical availability and reactivity of functional groups grafted to magnetic nanoparticles monitored in situ by ATR-IR spectroscopyChem Mater20092143164322
  • HammondCThe Basics Of Crystallography and DiffractionOxford, UKOxford University Press1997
  • GirgisEWahshMMSOthmanAGMBandhuLRaoKVSynthesis, magnetic and optical properties of core/shell Co1−xZnxFe2O4/SiO2 nanoparticlesNanoscale Res Lett2011646021774807
  • TornoMDKaminskiMDXieYImprovement of in vitro thrombolysis employing magnetically-guided microspheresThrombosis Res2008121799811
  • MahmoudiMSantSWangBLaurentSSenTSuperparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapyAdv Drug Deliv Rev201163244620685224
  • KonerackaMKopcanskyPAntalikMTimkoMRamchandCNLoboDImmobilization of proteins and enzymes to fine magnetic particlesJ Magn Magn Mater1999201427430
  • GoissisGMarcantonioEJrMarcantonioRACLiaRCCCancianDCJDe CarvalhoWMBiocompatibility studies of anionic collagen membranes with different degree of glutaraldehyde cross-linkingBiomaterials19992027349916768
  • TrowbridgeEACroftsCEThe extension rate independence of the hysteresis in glutaraldehyde-fixed bovine pericardiumBiomaterials198782012063111555
  • KempeHKempeMThe use of magnetite nanoparticles for implant-assisted magnetic drug targeting in thrombolytic therapyBiomaterials2010319499951020732712
  • YoshiokaSIzutsuKAsoYTakedaYInactivation kinetics of enzyme pharmaceuticals in aqueous solutionPharm Res199184804841871043
  • JohnsonPAParkHJDriscollAJEnzyme nanoparticle fabrication: magnetic nanoparticle synthesis and enzyme immobilizationMethods Mol Biol201167918319120865397
  • HongJXuDGongPYuJMaHYaoSCovalent-bonded immobilization of enzyme on hydrophilic polymer covering magnetic nanogelsMicroporous Mesoporous Mater2008109470477
  • LeeDGPonvelKMKimMHwangSAhnISLeeCHImmobilization of lipase on hydrophobic nano-sized magnetite particlesJ Mol Catal B Enzym2009576266
  • GangulyKKrasikTMedinillaSBlood clearance and activity of erythrocyte-coupled fibrinolyticsJ Pharmacol Exp Ther20053121106111315525799
  • LoskutoffDJSawdeyMMimuroJType 1 plasminogen activator inhibitorProg Hemost Thromb19899871152492381
  • GangulyKMurcianoJCWestrickRLeferovichJCinesDBMuzykantovVRThe glycocalyx protects erythrocyte-bound tissue-type plasminogen activator from enzymatic inhibitionJ Pharmacol Exp Ther200732115816417215448
  • MadisonELGoldsmithEJGerardRDGethingMJSambrookJFBassel-DubyRSAmino acid residues that affect interaction of tissue-type plasminogen activator with plasminogen activator inhibitor 1Proc Natl Acad Sci U S A199087353035332110366
  • DiamondSLEngineering design of optimal strategies for blood clot dissolutionAnnu Rev Biomed Eng1999142746211701496
  • DiamondSLAnandSInner clot diffusion and permeation during fibrinolysisBiophys J199365262226438312497
  • PleydellCPDavidTSmyeSWBerridgeDCA mathematical model of post-canalization thrombolysisPhys Med Biol20024720922411837613